Predictors of response to lithium and lamotrigine prophylaxis in bipolar I disorder

被引:2
|
作者
Ketter, T
Bowden, C
Vieta, E
Goldberg, JF
Antonijevic, Z
Leadbetter, R
机构
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA
[3] Univ Barcelona, E-08007 Barcelona, Spain
[4] Cornell Univ, Ctr Med, Ithaca, NY 14853 USA
[5] GlaxoSmithKline, Res Triangle Pk, NC USA
关键词
D O I
10.1016/S0924-977X(03)91927-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S267 / S267
页数:1
相关论文
共 50 条
  • [21] Clinical predictors of long-term outcome of lithium prophylaxis in bipolar disorder
    García-López, A
    Ezquiaga, E
    Nieves, P
    Rodríguez-Salvanés, F
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2001, 29 (05): : 327 - 332
  • [22] Non-genetic predictors of lithium response in bipolar disorder
    Bellivier, F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S23 - S23
  • [23] Personalized pharmacotherapy for bipolar disorder: genetic predictors of response to lithium
    Kelsoe, J. R.
    Leckband, S. G.
    Demodena, A.
    McCarthy, M.
    Shekhtman, T.
    BIPOLAR DISORDERS, 2012, 14 : 42 - 42
  • [24] Migraine history and lithium response in bipolar disorder I
    Sekula, Nicole
    Yocum, Anastasia
    Anderau, Steven
    McInnis, Melvin
    Marshall, David
    BIPOLAR DISORDERS, 2021, 23 : 60 - 61
  • [25] Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder
    Sachs, G
    Bowden, C
    Calabrese, JR
    Ketter, T
    Thompson, T
    White, R
    Bentley, B
    BIPOLAR DISORDERS, 2006, 8 (02) : 175 - 181
  • [26] Safety and tolerability of lamotrigine in bipolar I disorder
    Vieta, E
    Young, A
    Berk, M
    Asnis, G
    Calabrese, J
    Sachs, G
    Bowden, C
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S265 - S265
  • [27] Safety and tolerability of lamotrigine in bipolar I disorder
    Vieta, E
    Young, A
    Berk, M
    Asnis, G
    Sachs, G
    Bowden, C
    Calabrese, J
    BIPOLAR DISORDERS, 2004, 6 : 33 - 34
  • [28] Effects of lithium and lamotrigine on body weight after 18 months in bipolar I disorder
    Calabrese, J
    Young, AH
    Bowden, C
    Antonijevic, Z
    Evoniuk, G
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S265 - S265
  • [29] Lack of mania prophylaxis associated with lamotrigine monotherapy in manic-predominant bipolar I disorder
    Dossett, Emily C.
    Land, Alisa J.
    Gitlin, Michael J.
    Frye, Mark A.
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (06) : 973 - 974
  • [30] Lamotrigine in the therapy of patients with bipolar I and bipolar II disorder
    Schön, S
    Grunze, H
    PSYCHOPHARMAKOTHERAPIE, 2004, 11 (02): : 42 - 49